| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.06 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.06 |